🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a 52 week, single center, randomized, double-blind, placebo-control...
Status
Recruiting
Location
Hospital for Special Surgery
Start Date
2019-07-29
Trial ID
NCT03844061
Treatments Being Tested
This two year study will evaluate the effects of giving belimumab (Benlysta...
Status
Recruiting
Location
Feinstein Institute
Start Date
2020-09-15
Trial ID
NCT03543839
Treatments Being Tested
The main clinical study will be a randomized, double-blind, placebo-control...
Status
Withdrawn
Location
GSK Investigational Site
Start Date
2013-04
Trial ID
NCT01762852
Treatments Being Tested
Chronic immune thrombocytopenia (ITP) is a longterm disease in which the bl...
Status
Withdrawn
Location
Multiple Locations
Start Date
2013-03
Trial ID
NCT01440361
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of 3 diffe...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2003-12
Trial ID
NCT00071812
Treatments Being Tested
The purpose of this study is to evaluate the efficacy, safety, and tolerabi...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-02-19
Trial ID
NCT01632241
Treatments Being Tested
The purpose of this study is to evaluate the efficacy, safety, and tolerabi...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-07-12
Trial ID
NCT01639339
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of 3 diffe...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2003-10
Trial ID
NCT00071487
Treatments Being Tested
The goal of the trial is to evaluate the efficacy and safety of belimumab a...
Status
Completed
Location
Northwell Health Divison of Rheumatology
Start Date
2015-01
Trial ID
NCT02347891
Mechanistic study to assess whether dual B-cell immunotherapy by co-adminis...
Status
Unknown
Location
Addenbrooke's Hospital
Start Date
2019-02-01
Trial ID
NCT03967925
Treatments Being Tested